KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Taylor Morrison Home (TMHC) Net Income towards Common Stockholders (2017 - 2026)

Taylor Morrison Home has reported Net Income towards Common Stockholders over the past 14 years, most recently at $100.4 million for Q1 2026.

  • For Q1 2026, Net Income towards Common Stockholders fell 53.01% year-over-year to $100.4 million; the TTM value through Mar 2026 reached $678.0 million, down 25.43%, while the annual FY2025 figure was $791.3 million, 10.75% down from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 was $100.4 million at Taylor Morrison Home, down from $177.1 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $309.2 million in Q3 2022 and troughed at $100.4 million in Q1 2026.
  • A 5-year average of $212.0 million and a median of $199.9 million in 2024 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: skyrocketed 134.98% in 2022 and later plummeted 53.01% in 2026.
  • Year by year, Net Income towards Common Stockholders stood at $275.4 million in 2022, then plummeted by 37.12% to $173.2 million in 2023, then skyrocketed by 40.92% to $244.0 million in 2024, then fell by 27.43% to $177.1 million in 2025, then crashed by 43.29% to $100.4 million in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for TMHC at $100.4 million in Q1 2026, $177.1 million in Q4 2025, and $204.5 million in Q3 2025.